Gyre Therapeutics, Inc. · NASDAQ:GYRE

Gyre Therapeutics, Inc. insider trades

Gyre Therapeutics, Inc.'s insiders made 0 buys and 18 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

Insider trades

InsiderTradeSharesPriceValueDate
Ye Weiguo
Officer: Chief Operating Officer
Sale3,000USD 6.35US$19,050Jun 18, 2026
Ye Weiguo
Officer: Chief Operating Officer
Sale2,800USD 6.17US$17,276Jun 11, 2026
Ye Weiguo
Officer: Chief Operating Officer
Sale5,000USD 6.24US$31,200Jun 10, 2026
Ye Weiguo
Officer: Chief Operating Officer
Sale6,418USD 6.21US$39,856Jun 10, 2026
Ye Weiguo
Officer: Chief Operating Officer
Sale3,000USD 6.15US$18,450Jun 9, 2026
Ye Weiguo
Officer: Chief Operating Officer
Sale14,500USD 6.14US$89,030Jun 9, 2026
Ye Weiguo
Officer: Chief Operating Officer
Sale15,401USD 6.40US$98,566Jun 5, 2026
Ye Weiguo
Officer: Chief Operating Officer
Sale19,575USD 6.13US$120KJun 4, 2026
Ye Weiguo
Officer: Chief Operating Officer
Sale4,000USD 6.10US$24,400May 26, 2026
Ye Weiguo
Officer: Chief Operating Officer
Sale3,500USD 6.08US$21,280May 22, 2026
Ye Weiguo
Officer: Chief Operating Officer
Sale12,820USD 6.15US$78,843May 21, 2026
Ye Weiguo
Officer: Chief Operating Officer
Sale9,400USD 6.15US$57,810May 20, 2026
Ye Weiguo
Officer: Chief Operating Officer
Sale9,120USD 6.37US$58,094May 19, 2026
Ye Weiguo
Officer: Chief Operating Officer
Sale200USD 6.62US$1,324May 18, 2026
Ye Weiguo
Officer: Chief Operating Officer
Sale13,100USD 6.65US$87,115May 15, 2026
Ye Weiguo
Officer: Chief Operating Officer
Sale15,580USD 6.91US$108KMay 14, 2026
Luo Ying
Director, Officer: Chief Executive Officer
Sale10,136USD 8.04US$81,493May 6, 2026
Luo Ying
Director, Officer: Chief Executive Officer
Sale179USD 8.01US$1,434May 5, 2026

Gyre Therapeutics, Inc. shareholders